THe US Food and Drug
Administration has granted
approval for Anthim (obiltoxaximab)
injection for the treatment
of inhalational anthrax, in
combination with appropriate
antibacterial drugs.
Inhalational anthrax is a rare
disease that can occur after
exposure to infected animals or
contaminated animal products,
or as a release of an intentional
release of anthrax spores.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Mar 16
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.